Sage Therapeutics, Inc.
NASDAQ:SAGE
6.32 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -541.489 | -532.784 | -457.892 | 606.073 | -680.238 | -372.882 | -270.12 | -158.987 | -94.495 | -33.811 | -18.281 | -9.632 |
| Depreciation & Amortization
| 1.393 | 1.122 | 4.182 | 2.63 | 2.283 | 1.143 | 0.531 | 0.281 | 0.115 | 0.051 | 0.047 | 0.044 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 73.367 | 61.602 | 104.629 | 95.994 | 153.231 | 101.963 | 35.534 | 23.02 | 15.24 | 2.512 | 0.061 | 0 |
| Change In Working Capital
| -67.384 | 5.671 | -18.506 | -39.729 | 6.658 | 19.212 | 15.176 | 17.478 | 7.248 | 4.079 | 0.593 | 0.662 |
| Accounts Receivables
| -69.349 | 4.846 | -18.506 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 69.349 | -4.846 | 18.506 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -8.495 | 8.433 | 6.689 | -11.511 | -18.783 | 24.544 | -3.693 | 7.796 | 2.69 | 0.441 | 0.674 | 0.609 |
| Other Working Capital
| -58.889 | -2.762 | -6.689 | -28.218 | 25.441 | -5.332 | 18.869 | 9.682 | 4.558 | 3.638 | -0.081 | 0.053 |
| Other Non Cash Items
| -6.472 | 4.353 | -10.595 | -0.688 | -10.64 | -10.107 | -0.398 | -0.47 | 1.211 | 0.127 | 0.064 | 0.662 |
| Operating Cash Flow
| -540.585 | -460.036 | -378.182 | 664.28 | -528.706 | -260.671 | -219.277 | -118.678 | -70.681 | -27.042 | -17.516 | -8.926 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.553 | -0.937 | -0.372 | -0.345 | -5.751 | -2.86 | -1.36 | -1.421 | -0.198 | -0.128 | -0.003 | -0.111 |
| Acquisitions Net
| -442.913 | -326.37 | 1,002.076 | -443.029 | 137.405 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -594.67 | -881.037 | -1,990.151 | -458.72 | -1,308.675 | -1,484.358 | -244.403 | -259.093 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 1,038.136 | 1,207.407 | 988.075 | 901.749 | 1,171.27 | 974.757 | 261.225 | 30.499 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 442.913 | 326.37 | -1,002.076 | 443.029 | -137.405 | -509.601 | -0.285 | -0.525 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 442.913 | 325.433 | -1,002.448 | 442.684 | -143.156 | -512.461 | 15.177 | -230.54 | -0.198 | -0.128 | -0.003 | -0.111 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | -6.298 | -5.738 | -6.789 | -2.804 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 6.93 | 3.113 | 14.719 | 417.5 | 561.277 | 631.494 | 326.025 | 330.175 | 129.72 | 96.295 | 0.051 | 0.003 |
| Common Stock Repurchased
| -0.903 | -0.043 | -1.385 | 0 | -2.175 | -0.904 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 6.93 | 9.526 | 13.334 | 16.051 | 51.955 | 27.864 | 15.793 | 0.807 | 0.146 | 50.575 | 22.732 | 8.994 |
| Financing Cash Flow
| 6.027 | 3.07 | 13.334 | 426.762 | 607.624 | 659.358 | 341.818 | 330.982 | 129.866 | 146.87 | 22.783 | 8.997 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 540.585 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -91.645 | -131.533 | -1,367.296 | 1,533.726 | -64.238 | -113.774 | 137.718 | -18.236 | 58.987 | 119.7 | 5.264 | -0.04 |
| Cash At End Of Period
| 72.324 | 163.969 | 295.502 | 1,662.798 | 129.072 | 193.31 | 306.235 | 168.517 | 186.753 | 127.766 | 8.066 | 2.802 |